Intellia Therapeutics shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $2.3M | 260k | 8.99 |
| 2022-09-30 | $9.0M | 160k | 55.96 |
| 2022-06-30 | $1.5M | 29k | 51.76 |
| 2022-03-31 | $766k | 11k | 72.70 |
| 2021-09-30 | $8.3M | 62k | 134.14 |
| 2021-06-30 | $11M | 66k | 161.91 |
| 2021-03-31 | $1.3M | 16k | 80.28 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management